dc.contributor.author |
ANAND, SAURABH |
en_US |
dc.contributor.author |
MARDHEKAR, SANDHYA |
en_US |
dc.contributor.author |
RAIGAWALI, RAKESH |
en_US |
dc.contributor.author |
MOHANTA, NIRMALA |
en_US |
dc.contributor.author |
JAIN, PRASHANT |
en_US |
dc.contributor.author |
SHANTHAMURTHY, CHETHAN D. |
en_US |
dc.contributor.author |
GNANAPRAKASAM, BOOPATHY |
en_US |
dc.contributor.author |
KIKKERI, RAGHAVENDRA |
en_US |
dc.date.accessioned |
2020-05-22T13:07:13Z |
|
dc.date.available |
2020-05-22T13:07:13Z |
|
dc.date.issued |
2020-04 |
en_US |
dc.identifier.citation |
Organic Letters, 22(9), 3402-3406. |
en_US |
dc.identifier.issn |
1523-7060 |
en_US |
dc.identifier.issn |
1523-7052 |
en_US |
dc.identifier.uri |
http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/4609 |
|
dc.identifier.uri |
https://doi.org/10.1021/acs.orglett.0c00878 |
en_US |
dc.description.abstract |
We report for the first time a continuous-flow strategy to execute O-sulfation modification of heparan sulfate (HS) oligosaccharides. A systematic investigation of the influence of the flow parameters on the installation of the sulfate group on glucosamine monosaccharide can aid the development of a comprehensive, quick, and reliable strategy for O-sulfation of HS oligosaccharide precursors. Deprotection of the sulfated heparin intermediates led to the development of a comprehensive biologically inspired oligosaccharide library to understand the crucial structure–function relationship of HS. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
American Chemical Society |
en_US |
dc.subject |
Binding |
en_US |
dc.subject |
Oligosaccharides |
en_US |
dc.subject |
Activation |
en_US |
dc.subject |
TOC-MAY-2020 |
en_US |
dc.subject |
2020 |
en_US |
dc.subject |
2020-MAY-WEEK3 |
en_US |
dc.title |
Continuous-Flow Accelerated Sulfation of Heparan Sulfate Intermediates |
en_US |
dc.type |
Article |
en_US |
dc.contributor.department |
Dept. of Chemistry |
en_US |
dc.identifier.sourcetitle |
Organic Letters |
en_US |
dc.publication.originofpublisher |
Foreign |
en_US |